BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 236 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,916,620 | +36.8% | 270,709 | +36.0% | 0.24% | +25.4% |
| Q2 2023 | $1,401,516 | +52.1% | 199,079 | +80.2% | 0.19% | +54.4% |
| Q1 2023 | $921,178 | +31.8% | 110,453 | +81.4% | 0.12% | +10.6% |
| Q4 2022 | $698,902 | -13.5% | 60,880 | -5.1% | 0.11% | -7.4% |
| Q3 2022 | $808,000 | +96.1% | 64,149 | -25.9% | 0.12% | +335.7% |
| Q2 2020 | $412,000 | -42.6% | 86,518 | -33.0% | 0.03% | -3.4% |
| Q2 2017 | $718,000 | -33.8% | 129,200 | 0.0% | 0.03% | -49.1% |
| Q1 2017 | $1,085,000 | +31.0% | 129,200 | -1.2% | 0.06% | +5.6% |
| Q4 2016 | $828,000 | +16.0% | 130,794 | -19.2% | 0.05% | +28.6% |
| Q3 2016 | $714,000 | -36.2% | 161,900 | +116.0% | 0.04% | +44.8% |
| Q2 2015 | $1,119,000 | +62.4% | 74,960 | +6.4% | 0.03% | +61.1% |
| Q3 2014 | $689,000 | -46.3% | 70,474 | -29.9% | 0.02% | -47.1% |
| Q2 2014 | $1,282,000 | +203.1% | 100,514 | +151.4% | 0.03% | +240.0% |
| Q1 2014 | $423,000 | -38.9% | 39,974 | -56.1% | 0.01% | -88.0% |
| Q4 2013 | $692,000 | +179.0% | 91,100 | +167.5% | 0.08% | +1085.7% |
| Q3 2013 | $248,000 | – | 34,057 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |